European Spine Journal

, Volume 22, Issue 12, pp 2766–2769 | Cite as

Renal function in a rat model of neurogenic bladder, effect of statins and phosphodiesterase-5 inhibitors

  • Iraj Mirzaii-DizgahEmail author
  • Bahram Salmanyan
Original Article



Neurogenic bladder is a common complication of several central nervous system injuries. Statins and phosphodiesterase-5 (PDE-5) inhibitors are reportedly beneficial in neural injuries and urinary system dysfunction. The effect of simvastatin, sildenafil and tadalafil on several renal function indices of an animal model of neurogenic bladder was investigated.


Forty male rats were assessed in five equal groups. Dura mater and the cord were injured with an aneurysmal clamp at the level of T9–T10 in all rats except in sham group. The sham and control groups (treated by normal saline), simvastatin (4 mg/kg), sildenafil (5 mg/kg), and tadalafil (2 mg/kg) groups received treatment (i.p.) for seven consecutive days following injury. Renal system and motor functions were assessed at day 28 following injury. Data were analyzed by analysis of variance followed by the Student–Newman–Keuls post hoc test.


Simvastatin improved both the renal and the motor function compared with the control group. However, sildenafil and tadalafil could only improve the motor function but could not make any significant differences in renal indices in comparison with the control group.


Statins can effectively improve the motor and renal functions in a condition of renal dysfunction in a rat model of neurogenic bladder. PDE-5 inhibitors could help to improve motor function, but are not helpful in renal function, at least in short time.


Neurogenic bladder Phosphodiesterase-5 inhibitors Statins 


Conflict of interest



  1. 1.
    Ku JH (2006) The management of neurogenic bladder and quality of life in spinal cord injury. BJU Int 98:739–745PubMedCrossRefGoogle Scholar
  2. 2.
    Bauer SB (2008) Neurogenic bladder: etiology and assessment. Pediatr Nephrol 23:541–551PubMedCrossRefGoogle Scholar
  3. 3.
    Wu HY, Baskin LS, Kogan BA (1997) Neurogenic bladder dysfunction due to myelomeningocele: neonatal versus childhood treatment. J Urol 157:2295–2297PubMedCrossRefGoogle Scholar
  4. 4.
    Panicker JN, de Sèze M, Fowler CJ (2010) Rehabilitation in practice: neurogenic lower urinary tract dysfunction and its management. Clin Rehabil 24:579–589PubMedCrossRefGoogle Scholar
  5. 5.
    Scales CD Jr, Wiener JS (2008) Evaluating outcomes of enterocystoplasty in patients with spina bifida: a review of the literature. J Urol 180:2323–2329PubMedCrossRefGoogle Scholar
  6. 6.
    Pahan K, Sheikh FG, Namboodiri AM, Singh I (1997) Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Invest 100(11):2671–2679PubMedCrossRefGoogle Scholar
  7. 7.
    Paintlia AS, Paintlia MK, Singh I, Singh AK (2008) Combined medication of lovastatin with rolipram suppresses severity of experimental autoimmune encephalomyelitis. Exp Neurol 214(2):168–180PubMedCrossRefGoogle Scholar
  8. 8.
    Lin CL, Cheng H, Tung CW, Huang WJ, Chang PJ, Yang JT, Wang JY (2008) Simvastatin reverses high glucose-induced apoptosis of mesangial cells via modulation of Wnt signaling pathway. Am J Nephrol 28:290–297PubMedCrossRefGoogle Scholar
  9. 9.
    Tsujihata M, Momohara C, Yoshioka I, Tsujimura A, Nonomura N, Okuyama A (2008) Atorvastatin inhibits renal crystal retention in a rat stone forming model. J Urol 180:2212–2217PubMedCrossRefGoogle Scholar
  10. 10.
    Shunmugavel A, Khan M, Te Chou PC, Dhindsa RK, Martin MM, Copay AG, Subach BR, Schuler TC, Bilgen M, Orak JK, Singh I (2010) Simvastatin protects bladder and renal functions following spinal cord injury in rats. J Inflamm (Lond) 7:17CrossRefGoogle Scholar
  11. 11.
    Roehrborn CG, McVary KT, Elion-Mboussa A, Viktrup L (2008) Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study. J Urol 180:1228–1234PubMedCrossRefGoogle Scholar
  12. 12.
    Oger S, Behr-Roussel D, Gorny D, Lebret T, Validire P, Cathelineau X, Alexandre L, Giuliano F (2010) Signalling pathways involved in sildenafil-induced relaxation of human bladder dome smooth muscle. Br J Pharmacol 160(5):1135–1143PubMedCrossRefGoogle Scholar
  13. 13.
    Caremel R, Oger-Roussel S, Behr-Roussel D, Grise P, Giuliano FA (2010) Nitric oxide/cyclic guanosine monophosphate signalling mediates an inhibitory action on sensory pathways of the micturition reflex in the rat. Eur Urol 58:616–625PubMedCrossRefGoogle Scholar
  14. 14.
    Thomas C, Kim JH, Torimoto K, Kwon DD, Kim YT, Tyagi P, Yoshimura N, Chancellor MB (2007) Early capsaicin intervention for neurogenic bladder in a rat model of spinal cord injury. Biomed Res 28(5):255–259PubMedCrossRefGoogle Scholar
  15. 15.
    De Groat WC, Yoshimura N (2010) Changes in afferent activity after spinal cord injury. Neurourol Urodyn 29:63–76PubMedCrossRefGoogle Scholar
  16. 16.
    Basso DM, Beattie MS, Bresnahan JC (1996) Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 139:244–256PubMedCrossRefGoogle Scholar
  17. 17.
    Kim D, Sands JM, Klein JD (2003) Changes in renal medullary transport proteins during uncontrolled diabetes mellitus in rats. Am J Physiol Renal Physiol 285(2):F303–F309PubMedGoogle Scholar
  18. 18.
    Mimata H, Satoh F, Tanigawa T, Nomura Y, Ogata J (1993) Changes of rat urinary bladder during acute phase of spinal cord injury. Urol Int 51:89–93PubMedCrossRefGoogle Scholar
  19. 19.
    Serarslan Y, Yönden Z, Ozgiray E, Oktar S, Güven EO, Söğüt S, Yilmaz N, Yurtseven T (2010) Protective effects of tadalafil on experimental spinal cord injury in rats. J Clin Neurosci 17(3):349–352PubMedCrossRefGoogle Scholar
  20. 20.
    Agarwal R (2006) Effects of statins on renal function. Am J Cardiol 97(5):748–755PubMedCrossRefGoogle Scholar
  21. 21.
    Choi K, Kang SW, Lee SW, Lee HY, Han DS, Kang BS (1995) The effect of lovastatin on proliferation of cultured rat mesangial and aortic smooth muscle cells. Yonsei Med J 36:251–261PubMedGoogle Scholar
  22. 22.
    Khan SR (2005) Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol Res 33:349–357PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Department of Physiology, School of MedicineAja University of Medical SciencesTehranIran

Personalised recommendations